Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from Walgreens Boots Alliance ( (WBA) ) is now available.
Walgreens Boots Alliance announced its fiscal 2025 first quarter results, highlighting a 7.5% increase in sales to $39.5 billion, despite a decrease in adjusted earnings per share from $0.66 to $0.51. The company maintains its full-year adjusted EPS guidance, with challenges in U.S. retail sales and higher tax rates balanced by growth in U.S. Healthcare and international segments. The company is focused on strategic priorities, including stabilizing retail pharmacy and enhancing cost efficiencies, although it reported a net loss of $265 million due to increased operating costs and lower retail sales.
More about Walgreens Boots Alliance
Walgreens Boots Alliance is a prominent player in the retail pharmacy and healthcare industry, providing pharmacy services and health-focused retail products. It operates primarily in the U.S. and international markets, with a strategic focus on optimizing retail pharmacy operations while expanding its healthcare services.
YTD Price Performance: 0.33%
Average Trading Volume: 23,641,090
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.96B
See more insights into WBA stock on TipRanks’ Stock Analysis page.
